Clinical Trial Update: Bevacizumab and Carboplatin/Paclitaxel and Radiation in Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating bevacizumab with carboplatin/paclitaxel and radiation in non-small cell lung cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Avastin (bevacizumab)
• CARBOPLATIN (Carboplatin)
• Taxol (paclitaxel)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Non-Small Cell Lung Cancer | Phase 2 | Status: COMPLETED